| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a89a06a412cb20ea86db0c71c4a62cb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2021-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86ec8e6367ceb83252dad70552a0aa35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea71e6de50f0edd55d63171cb7f6a370
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9373f9ad2d0c092186ab1cf83cb03d4d |
| publicationDate |
2022-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022053549-A1 |
| titleOfInvention |
Use of c-myc as a biomarker of drug response |
| abstract |
The present invention provides use of c-Myc as a biomarker for predicting the response of a brain neoplasm to a compound of formula (I) or pharmaceutically acceptable salt thereof or a prodrug or pharmaceutically acceptable salt of a prodrug thereof. The invention also provides methods of treatment and kits for use according to the invention. |
| priorityDate |
2020-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |